Tamaño de muestra de protocolos clínicos

Area of Science:

• Clinical Research Methodology
• Biostatistics
• Drug Development

Background:

• Sample size calculation is a critical step in clinical trial protocol development.
• Common issues include insufficient data, outdated formulas, and inappropriate equation selection.
• These errors can compromise study validity and statistical power.

Purpose of the Study:

• To identify and address common problems in sample size calculations for clinical protocols.
• To define the essential data required for accurate sample size determination.
• To improve the quality of clinical trial protocols submitted for review.

Main Methods:

• Review of clinical protocols submitted to the institutional review board.
• Analysis of common errors in sample size calculation methodologies.
• Identification of key parameters for sample size determination in superiority and non-inferiority trials.

Main Results:

• Frequent issues identified: insufficient data, use of obsolete equations (ignoring beta error), and incorrect equation selection based on study design.
• Four essential data points are identified for inclusion in clinical protocols.
• Guidelines provided for superiority (drug vs. placebo) and non-inferiority (drug vs. active control) trials.

Conclusions:

• Addressing common sample size calculation errors is vital for clinical trial integrity.
• Standardizing the inclusion of four key data points will enhance protocol quality.
• Accurate sample size determination ensures reliable and valid research findings.